arrow
F

Frits van Rhee

University of Arkansas for Medical Sciences
H指数:82
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma

在复发/难治性多发性骨髓瘤的双特异性抗体治疗期间,淋巴细胞动力学和免疫组成的预后影响

2026-08-220
OAAI
Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients

更正:接受teclistamab治疗的多发性骨髓瘤患者中巨细胞病毒再激活的临床结局和危险因素

2026-08-070
OAAI
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients

细胞巨病毒再激活的临床结局和危险因素:在teclistamab治疗的复发性/难治性多发性骨髓瘤患者中

2026-03-310
OAAI
Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma

外周血免疫细胞特征分析及对BCMA CAR-T细胞治疗的反应,在复发难治性多发性骨髓瘤中的应用

2026-01-060
OAAI
Idiopathic Multicentric Castleman Disease Unresponsive to One IL-6 Inhibitor May Respond to Another IL-6 Inhibitor

原发性多中心性Castleman病对一种IL-6抑制剂无反应可能对另一种IL-6抑制剂有反应

2026-01-010
OAAI
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study

Talquetamab在复发难治性多发性骨髓瘤中的应用:多中心真实世界研究

2025-11-070
OAAI
Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans

黑人美国人和白人美国人在多发性骨髓瘤患者适当匹配时的生存率相同

2025-10-160
OA
The Involvement of PI3K-Akt Signaling in the Clinical and Pathological Findings of Idiopathic Multicentric Castleman Disease-Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, and Organomegaly and Not Otherwise Specified Subtypes

PI3K-Akt信号通路在特发性多中心性卡斯特曼病(临床和病理表现包括血小板减少、全身水肿、发热、网状纤维化及器官肿大)及未另行指定亚型中的参与作用

2025-05-160
OAAI
Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data

利用SKY92基因表达谱分析真实世界数据,以提升多发性骨髓瘤的风险分层和治疗决策。

2025-04-150
PRE
Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patients

常见的结缔组织疾病和抗细胞因子自身抗体在特发性多中心性Castleman病患者中富集。

2025-03-130
OA
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns

探索Castleman Disease和TAFRO Syndrome的临床多样性:一项关于淋巴结分布模式的日本多中心研究

2025-01-251
OAAI